Nemluvio 30 MG
Ended Awarded Last action
- Contract number
- 36C24526N0514
- Awardee
-
Galderma Laboratories, L.P. UEI MNX4XY6QXEL3
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $42,400
Award facts
- Contract value 100% obligated
- $42,400.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order to Galderma Laboratories, L.P. on April 15, 2026, for the supply of Nemluvio 30 mg injectable pharmaceutical product. This firm fixed-price delivery order carries a ceiling value of $42.4K with an ultimate completion date of April 17, 2026, reflecting the time-sensitive nature of pharmaceutical supply to VA patient care operations. The contract was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and includes no set-aside designation. Galderma Laboratories, headquartered in Dallas, Texas, will perform the work in Carrollton, TX.
Galderma Laboratories has established itself as a specialized supplier of injectable pharmaceuticals to the VA healthcare system, with consistent federal contractor registration since February 2002. The company's contract portfolio demonstrates focused expertise in supplying Nemolizumab and Nemluvio formulations across multiple VISN regions. This delivery order represents part of an ongoing pharmaceutical supply relationship supporting VA patient care requirements across the Veterans Health Administration's distributed healthcare networks.
Quick answers
Who was awarded contract 36C24526N0514?
36C24526N0514 was awarded to Galderma Laboratories, L.P. by Veterans Integrated Service Network 5 (Veterans Health Administration) on April 15, 2026.
How much is contract 36C24526N0514 worth?
The government has obligated $42,400 on 36C24526N0514.
Is contract 36C24526N0514 an order under another contract?
Yes. 36C24526N0514 is a delivery order under V797D70255, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0514 competed?
The extent of competition for 36C24526N0514 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award